The efficacy of imiquimod on dysplastic lesions of the oral mucosa: An experimental model

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 2891-2896

  Gkoulioni, Vasiliki ^a   Eleftheriadou, Anna ^b   Yiotakis, Ioannis ^c   Ferekidou, Eliza ^c   Chrisovergis, Aristidis ^c   Lazaris, Andreas Ch ^c   Kandiloros, Dimitrios ^c  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b General Hospital of Rethymnon   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Imiquimod; Oral dysplasia; Treatment

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; IMIQUIMOD;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CHEEK POUCH; CONTROLLED STUDY; DRUG EFFICACY; DYSPLASIA; EXPERIMENTAL MODEL; HYPERPLASIA; MALE; MORPHOLOGY; MOUTH MUCOSA; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; RAT; SQUAMOUS CELL CARCINOMA;

9,10-DIMETHYL-1,2-BENZANTHRACENE; AMINOQUINOLINES; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; MALE; MOUTH MUCOSA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; RATS; RATS, WISTAR;

EID: 77955804299     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Lodi G, Sardella A, Bez C, Demarosi F and Crassi A: Systematic review of randomized trials for the treatment of oral leukoplakia. J Dent Educ 66(8): 11, 2002.
2. Van der Waal I, Schepman KP, Van der Meij EH and Smeele LE: Oral leukoplakia: a clinicopathological review. Oral Oncology 33(5): 291-301, 1997.
3. Navi D and Huntley A: Imiquimod 5 percent cream and the treatment of cutaneous malignancy. Dermatol Online J 10(1): 4, 2004.
4. Stanley MA: Imiquimod and the imidazoquinolines: mechanism of action and therapeutic potential. Clin Exp Dermatol 27(7): 571-577, 2002. (Pubitemid 35463873)
5. Schön MP and Schön M: Imiquimod: mode of action. Br J Dermatol 157(Suppl 2): 8-13, 2007.
6. Schön M, Bong AB, Drewniok C, Herz J, Geilen C, Reifenberger J, Benninghoff B, Slade HB, Gollnick H and Schon MP: Tumor-selective induction of apoptosis and the small-molecule response modifier imiquimod. J Natl Cancer Inst 95(15): 1138-1149, 2003.
7. Somani N and Rivers JK: Imiquimod 5% cream for the treatment of actinic keratoses. Skin Ther Lett 10(2): 1-6, 2005.
8. Salley JJ: Experimental carcinogenesis in the cheek pouch of the Syrian hamster. J Dent Res 33: 253-262, 1954.
9. Gimenez-Conti IB and Slaga TJ: The hamster cheek pouch carcinogenesis model. J Cell Biochem (Suppl17F): 83-90, 1993.
10. Schwartz J, Shklar G and Trickier D: Vitamin C enhances the development of carcinomas in the hamster buccal pouch experimental model. Oral Surg Oral Med Oral Pathol 76(6): 718-722, 1993.
11. Von Krogh G: Management of anogenital warts (condylomata acuminata). Eur J Dermatol 11(6): 598-603, 2001. (Pubitemid 33044469)
12. Scheinfeld N, Lehman DS: An evidence-based review of medical and surgical treatments of genital warts. Dematol Online J 12(3): 5, 2006.
13. Diamantis ML, Bartlett BL and Tyring SK: Safety, efficacy and recurrence rates of imiquimod cream 5% for treatment of anogenital warts. Skin Ther Lett 14(5): 1-3, 2009.
14. Quatresooz P, Piérard-Franchimont C, Paquet P, Hubert P, Delvenne P and Piérard GE: Crossroads between actinic keratosis and squamous cell carcinoma, and novel pharmacological issues. Eur J Dermatol 18(1): 6-10, 2008. (Pubitemid 351158165)
15. Dixon A: Treating actinic keratoses with imiquimod. Aust Fam Physician 36(5): 341-342, 2007.
16. Lacarrubba F, Nasca MR and Micali G: Advances in the use of topical imiquimod to treat dermatologic disorders. Ther Clin Risk Manag 4(1): 87-97, 2008. (Pubitemid 351460934)
17. Sapijaszko MJ: Imiquimod 5% cream (Aldara) in the treatment of basal cell carcinoma. Skin Ther Lett 10(6): 2-5, 2005.
18. Konstantopoulou M, Lord MG and Macfarlane AW: Treatment of invasive squamous cell carcinoma with 5-percent imiquimod cream. Dermatol Online J 12(3): 10, 2006.
19. Wenzel K, Saka B, Zimmermann R, Gundlach KK, Barten M and Gross G: Malignant conversion of florid oral and labial papillomatosis during topical immunotherapy with imiquimod. Med Microbiol Immunol 192(3): 161-164, 2003. (Pubitemid 37100662)
20. Rinaggio J, Glick M and Lambert WC: Oral bowenoid papulosis in an HIV-positive male. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(3): 328-332, 2006. (Pubitemid 43303811)
21. Conant MA: Immunomodulatory therapy in the management of viral infections in patients with HIV infection. J Am Acad Dermatol 43(1 Pt 2): S27-30, 2000.
22. Spieth K, Kovács A, Wolter M, Bug R, Kaufmann R and Gille J: Topical imiquimod: effectiveness in intraepithelial melanoma of oral mucosa. Lancet Oncol 7(12): 1036-1037, 2006. (Pubitemid 44804145)
23. Yasar S, Mansur AT, Serdar ZA, Goktay F and Asian C: Treatment of focal epithelial hyperplasia with topical imiquimod: report of three cases. Pediatr Dermatol 26(4): 465-468, 2009.
24. Allam JP, Erdsach T, Wenghoefer M, Bieber T, Appel TR and Novak M: Successful treatment of extensive human papillomavirus-associated oral leukoplakia with imiquimod. Br J Dermatol 158(3): 644-646, 2008. (Pubitemid 351239172)